What else did you see that you think you can pin on decriminalization? I think that

it's – again, it's important to emphasize that when we walked into this – There was a group of proponents and the government was contributing to this, saying, like, this is a solution or this is a major solution to the current drug crisis, that we're going to do this.

We're going to see that because of a combination of things, we're going to see less stigma, more treatment seeking.

People will be less likely to use drugs, you know, alone or in rushed circumstances and that we're going to see very, very significant and important decreases in overdose outcomes.

And opponents were saying this is going to normalize it.

This is reducing some of the conversations and we're going to see a surge in overdoses.

And, you know, and the results are saying it probably doesn't cause large impacts at the population level.

If you are a federal or provincial policymaker, if you are on the criminal justice side of the system, what's the takeaway here? How do we impact the opioid crisis?

Like, how do we know for sure that this is actually true, that this is not due to increased awareness and better diagnosis?

Yes, there's a couple of things.

So I think that there's a statistical method that we try and do.

There's a really interesting pattern when if you look at part of the challenge of these birth cohort studies is that the young people have not actually gotten, like someone born in 2000 has not made it to their 30s yet.

So you don't know what their pattern of psychosis is going to be because that's in the future from now.

And someone born in the 60s, because the health databases that we use to study them, they didn't exist when they were 14.

So you have this interesting pattern where the older birth cohorts, you only get to watch them later in life.

So is this kind of the moment where we need to start investing in these programs?